Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
Ludwig
W D
WD
Department of Hematology and Oncology, Klinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany.
Harbott
J
J
Bartram
C R
CR
Komischke
B
B
Sperling
C
C
Teichmann
J V
JV
Seibt-Jung
H
H
Notter
M
M
Odenwald
E
E
Nehmer
A
A
D000293:Adolescent; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015994:Incidence; D007223:Infant; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000188:drug therapy / Q000235:genetics / Q000276:immunology* / Q000401:mortality; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
D015703:Antigens, CD